| Name | Title | Contact Details |
|---|
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
Parkland is a diverse community of 30,000, and the City provides a variety of services for these citizens. Learn more about what Parkland has to offer you and your family! Parkland is a tranquil city nestled in a serene, wooded environment in Northwest...
National Surgical Hospitals is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. National Surgical Hospitals is based in Chicago, IL. You can find more information on National Surgical Hospitals at www.nshinc.com
Education Review Systems is a Tallahassee, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
East Hill Medical Group is a multi-specialty group practice that focuses on primary care, chiropractic, and aesthetic services.